November 9, 2016 by CDR Blog and Chain Drug Review
Deutsche Bank Securities, Federal Trade Commission, George Hill, private equity, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, WBA-Rite Aid merger
CDR Blog, Leading Headlines

Walgreens Boots Alliance and Rite Aid recently extended the agreement end date for their merger transaction until late January, with the expectation that the deal will get the Federal Trade Commission’s OK in early 2017. As WBA’s store divestiture talks with the FTC roll on, Deutsche Bank Securities analyst George Hill shed some light on
November 8, 2016 by Chain Drug Review
CVS Caremark, CVS Health, CVS Pharmacy, Deutsche Bank Securities, George Hill, Larry Merlo
Business, Featured Articles, Leading Headlines, Retail News

WOONSOCKET, R.I. — CVS Health posted sales gains in both of its business units and adjusted earnings per share above Wall Street’s forecast for the 2016 third quarter. However, CVS said Tuesday that it lowered its outlook for full-year 2016 and, in preliminary guidance for fiscal 2017, expects to lose over 40 million retail prescriptions
November 7, 2016 by Geoff Walden and Chain Drug Review
CVS Health, Deutsche Bank Securities, Federal Trade Commission, George Hill, Kroger, Rite Aid, Stefano Pessina, Walgreens Boots Alliance, Walmart, WBA-Rite Aid merger
2016, Issue 11-07-2016, Issues, News

DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Rite Aid Corp. have extended the time frame for completing their planned $17.2 billion merger. The companies have pushed back the end date for the deal by three months to January 27, and they expect the transaction to close early next year. Both companies had the
October 20, 2016 by Chain Drug Review
Deutsche Bank Securities, George Hill, Rite Aid, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill., and CAMP HILL, Pa. — Walgreens Boots Alliance (WBA) and Rite Aid Corp. are expanding the time frame for completing their planned $17.2 billion merger deal. WBA and Rite Aid said Thursday that they have extended the end date for the agreement to Jan. 27, 2017, from Oct. 27, 2016, and expect the
October 6, 2016 by Chain Drug Review
Deutsche Bank Securities, Fred's Pharmacy, Fred’s Inc., Michael Bloom, Paul Trussell
Business, Leading Headlines, Retail News

MEMPHIS, Tenn. — Impacted by pricing pressure and pharmacy industry trends, Fred’s Inc. reported decreased revenue and same-store sales for September. The discount retail and pharmacy chain said Thursday that for the five weeks ended Oct. 1, sales totaled $199.9 million, down 5.5% from $211.4 million a year earlier. Same-store sales fell 4.9% for September,
October 4, 2016 by Chain Drug Review
CVS, Deutsche Bank Securities, Express Scripts, George Hill, PBM, pharmacy benefit manager, Tricare, Walgreens
Leading Headlines, Pharmacy, Retail News

ST. LOUIS — Express Scripts Inc. is changing out CVS Pharmacy for Walgreens in its retail pharmacy network for TRICARE, the U.S. military’s health care and drug benefits program. Plans call for Walgreens pharmacies to join the Express Scripts network for TRICARE on Dec. 1. At that time, CVS pharmacies — including CVS locations in
July 9, 2015 by Chain Drug Review
Deutsche Bank Securities, fiscal 2015 third quarter, George Hill, James Skinner, Liz Earle Beauty, Mark Miller, Stefano Pessina, Walgreens, Walgreens Boots Alliance, William Blair & Co.
Business, Featured Articles, Leading Headlines, Retail News

DEERFIELD, Ill. — Walgreens Boots Alliance Inc. announced executive vice chairman Stefano Pessina as its permanent chief executive officer in reporting increased sales and earnings for its fiscal 2015 third quarter. The company said Thursday that its board of directors appointed Pessina as CEO, effective immediately. He had been serving as acting CEO since January,